Worldwide Healthcare Trust PLC is a closed-ended equity mutual fund launched by Frostrow Capital LLP and managed by OrbiMed Capital LLC. It invests in public equity markets worldwide, focusing on healthcare companies with an emphasis on pharmaceuticals and biotechnology. The fund primarily targets growth stocks of large-cap companies with a market capitalization of at least $5 billion, using fundamental analysis and a bottom-up stock picking approach. It benchmarks its performance against the MSCI World Healthcare Index and was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. The fund was formed in April 1995 and is domiciled in the United Kingdom.